Fortis Healthcare is currently trading at Rs. 288.30, up by 0.20 points or 0.07% from its previous closing of Rs. 288.10 on the BSE.
The scrip opened at Rs. 288.80 and has touched a high and low of Rs. 290.00 and Rs. 285.35 respectively. So far 12705 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 324.80 on 19-Sep-2022 and a 52 week low of Rs. 219.80 on 20-Jun-2022.
Last one week high and low of the scrip stood at Rs. 294.95 and Rs. 278.00 respectively. The current market cap of the company is Rs. 21761.67 crore.
The promoters holding in the company stood at 31.17%, while Institutions and Non-Institutions held 51.91% and 16.92% respectively.
Fortis Healthcare has reported net profit at Rs 2.07 crore for fourth quarter ended March 31, 2023 as compared to net loss of Rs 24.24 crore for the same quarter in the previous year. Total income of the company increased by 26.91% at Rs 307.59 crore for Q4FY23 as compared to Rs 242.37 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 58.91% rise in its net profit at Rs 138.30 crore for fourth quarter ended March 31, 2023 as compared to Rs 87.03 crore for the same quarter in the previous year. Total income of the company increased by 19.68% at Rs 1656.49 crore for Q4FY23 as compared to Rs 1384.09 crore for the corresponding quarter previous year.
For the year ended March 31, 2023, the company has reported net profit at Rs 96.24 crore as compared to net loss of Rs 13.25 crore for the previous year. Total income of the company increased by 20.65% at Rs 1202.50 crore for year under review as compared to Rs 996.71 crore for year ended March 31, 2022.
For the year ended March 31, 2023, on the consolidated basis, the company has reported 19.87% fall in its net profit at Rs 632.98 crore as compared to Rs 789.95 crore for the previous year. However, total income of the company increased by 10.69% at Rs 6359.35 crore for year under review as compared to Rs 5744.95 crore for year ended March 31, 2022.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 6932.35 |
| Max Healthcare Inst | 999.80 |
| Narayana Hrudayalay | 1271.85 |
| Aster DM Healthcare | 432.35 |
| Global Health | 1114.00 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Claim your FREE 15-day access to the most practical investing handbook.
Hurry, limited to the first 10 users today!
Become a savvy and confident
stock investor.
Don't miss out! First 10 users today get it FREE
Download APP
